Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose
- PMID: 18830212
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose
Abstract
On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine, DTaP-IPV (Kinrix, GlaxoSmithKline Biologicals, Rixensart, Belgium). Kinrix is licensed for use as the fifth dose of the DTaP vaccine series and the fourth dose of the IPV series in children aged 4-6 years whose previous DTaP vaccine doses were DTaP (Infanrix, GlaxoSmithKline) and/or DTaP-Hepatitis B-IPV (Pediarix, GlaxoSmithKline) for the first 3 doses and DTaP (Infanrix) for the fourth dose. DTaP-IPV administered to children aged 4-6 years would reduce by one the number of injections needed to complete DTaP and IPV immunization. This report summarizes the indications for Kinrix and provides guidance from the Advisory Committee on Immunization Practices (ACIP) for its use.
Similar articles
-
New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Ann Pharmacother. 2010. PMID: 20197476 Review.
-
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.MMWR Morb Mortal Wkly Rep. 2008 Oct 3;57(39):1079-80. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18830213
-
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose.MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):948-9. doi: 10.15585/mmwr.mm6434a5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26334944
-
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.Vaccine. 2007 Jan 22;25(6):1121-5. doi: 10.1016/j.vaccine.2006.09.053. Epub 2006 Oct 2. Vaccine. 2007. PMID: 17045366 Clinical Trial.
-
Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years.Expert Rev Vaccines. 2008 Nov;7(9):1309-20. doi: 10.1586/14760584.7.9.1309. Expert Rev Vaccines. 2008. PMID: 18980534 Review.
Cited by
-
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1. MMWR Recomm Rep. 2018. PMID: 29702631 Free PMC article.
-
The relationship between pediatric combination vaccines and market effects.Am J Public Health. 2014 Jun;104(6):998-1004. doi: 10.2105/AJPH.2013.301780. Epub 2014 Apr 17. Am J Public Health. 2014. PMID: 24825198 Free PMC article.
-
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.Public Health Rep. 2012 Jan-Feb;127(1):23-37. doi: 10.1177/003335491212700104. Public Health Rep. 2012. PMID: 22298920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
